AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

New NIH Study to Tackle Cardiovascular Heart Disease in HIV-infected Individuals

REPRIEVE trial logo

If you are HIV positive and on antiretroviral therapy (ART), are you doing all you can to maintain and improve your health?  While early diagnosis of HIV infection and use of combination ART has significantly reduced AIDS-related mortality and morbidity in the U.S., it does not completely return you to your pre-infection health status. For…

NIH launches largest clinical trial focused on HIV-related cardiovascular disease

nhlbi logo

Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI)…

Whitescarver steps down as director of NIH’s Office of AIDS Research

nih logo

Jack Whitescarver, Ph.D., who has led the Office of AIDS Research (OAR) at the National Institutes of Health since 2000, announced that he will step down from his post, effective July 1, 2015.  He also serves as NIH Associate Director for AIDS Research. The NIH will appoint an acting director for the office while it…

NIH, South African Medical Research Council award $8 million in HIV, TB grants

nih logo

The National Institutes of Health and the South African Medical Research Council (SAMRC) are awarding 31 grants to U.S. and South African scientists to support research targeting HIV/AIDS, tuberculosis and HIV-related co-morbidities and cancers. The awards, which total $8 million in first-year funding, are the first to be issued through the South Africa–U.S. Program for…

CROI 2015 Highlights: NIH’s Dr. Peter Kim Discusses Tuberculosis

croi2015_w280x100

Tuberculosis (TB) was among the several infectious diseases in addition to HIV that were important topics of discussion during the 2015 Conference on Retroviruses and Opportunistic Infections (CROI)  held in Seattle at the end of last month.  As the conference came to a close, we visited with Dr. Peter Kim about TB, his area of research at…

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

nih logo

For Immediate Release: Friday, March 6, 2015 Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat…

NIH Funding Opportunity for Drug Abuse Prevention Research Holds Potential for Addressing Viral Hepatitis

Ronald Valdiserri

The National Institute on Drug Abuse (NIDA), part of NIH, has released a Funding Opportunity Announcement (FOA) for research that will increase understanding of the science of drug use prevention within diverse populations and settings. Given the high prevalence of hepatitis C virus (HCV) infection among persons who inject drugs (PWID), this research also holds…

NIH-led study to assess community-based hepatitis C treatment in Washington, D.C.

nih logo

Officials from the National Institutes of Health and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection….